Literature DB >> 32727190

[Laparoscopic radical resection of rectal cancer with preservation of the left colic artery: anatomical basis and surgical experience].

M Zhong1, Y Luo1, M H Yu1.   

Abstract

In order to increase the blood supply of anastomosis, surgeons choose to preserve the left colon artery (LCA) during the laparoscopic radical resection of rectal cancer. However, surgeons are always ailed by hemorrhage and incompletely dissection of No. 253 lymph nodes. One reason is the shortage of understanding the relationship between inferior mesenteric artery (IMA), LCA, and inferior mesenteric vein before surgery. Another reason is that surgeon always remove the lymph nodes around LCA, while don't normatively resect No. 253 lymph nodes, which affect the overall survival rate. Therefore, the "medial-to-lateral approach" for laparoscopic preservation with LCA radical resection in rectal cancer was suggested in this article. The CT technique could be used to analyze the IMA classification, which contribuated to the standard conservation of LCA. Laparoscopic radical resection of rectal cancer could be completed of high quality, through accurate definition and exactly dissection of the No. 235 lymph nodes.

Entities:  

Keywords:  Laparoscopy; Left colic artery; Rectal neoplasms

Mesh:

Year:  2020        PMID: 32727190     DOI: 10.3760/cma.j.cn112139-20200325-00252

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  2 in total

1.  Adoption of Artificial Intelligence (AI)-Based Computerized Tomography (CT) Evaluation of Comprehensive Nursing in the Operation Room in Laparoscopy-Guided Radical Surgery of Colon Cancer.

Authors:  Xiuping Duan; Dechun Su; Haiwei Yu; Wei Xin; Yang Wang; Ziming Zhao
Journal:  Comput Intell Neurosci       Date:  2022-03-08

Review 2.  The significance of anatomical variation of the inferior mesenteric artery and its branches for laparoscopic radical resection of colorectal cancer: a review.

Authors:  Shun Zeng; Wenhao Wu; Xianbin Zhang; Tong Qiu; Peng Gong
Journal:  World J Surg Oncol       Date:  2022-09-10       Impact factor: 3.253

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.